Sartorius to open facility in Marlborough that will aid in production of COVID-19 vaccine, treatments

A biotechnology company plans to open a 40,000-square-foot facility in Marlborough in early 2021 that will aid in the development and manufacturing of COVID-19 vaccines and therapeutics.

Sartorius, international partner of life science research and the biopharmaceutical industry, announced Thursday that it plans to open a Customer Service Interaction Center in Marlborough. The site will create 100 new jobs.

Share This Post

MLSC Brandmark scaled 1